Ibaraki, undefined

Shigeru Okano

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Chemical Company, Limited. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeru Okano. Retrieved from https://idiyas.com/inventor/shigeru-okano-cro8i4yy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shigeru Okano: Innovator in Cephalosporanic Acid Derivatives

Introduction

Shigeru Okano is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporanic acid derivatives. His work has implications for the production of important antibiotic compounds.

Latest Patents

Shigeru Okano holds a patent for a process for producing cephalosporanic acid derivatives. This patent includes novel penicillin derivatives characterized by specific chemical formulas. The derivatives are useful as precursors for the production of cephalosporin derivatives. The improved process outlined in his patent enhances the production of these vital compounds.

Career Highlights

Okano is associated with Sumitomo Chemical Company, Limited, where he has been able to apply his expertise in pharmaceutical chemistry. His work has contributed to advancements in antibiotic development, showcasing his commitment to innovation in the field.

Collaborations

Throughout his career, Shigeru Okano has collaborated with esteemed colleagues such as Masataka Fukumura and Kaoru Maeshima. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Shigeru Okano's contributions to the field of pharmaceuticals, particularly through his patent on cephalosporanic acid derivatives, highlight his role as an innovator. His work continues to influence the development of important antibiotic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…